Hood River Capital Management LLC lifted its stake in LHC Group (NASDAQ:LHCG) by 2.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 257,980 shares of the health services provider’s stock after buying an additional 5,926 shares during the period. Hood River Capital Management LLC owned approximately 1.45% of LHC Group worth $17,514,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Alps Advisors Inc. grew its position in shares of LHC Group by 0.3% in the 2nd quarter. Alps Advisors Inc. now owns 9,449 shares of the health services provider’s stock valued at $641,000 after buying an additional 24 shares during the last quarter. Federated Investors Inc. PA grew its position in shares of LHC Group by 4.2% in the 2nd quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock valued at $110,000 after buying an additional 66 shares during the last quarter. Arizona State Retirement System grew its position in shares of LHC Group by 1.3% in the 2nd quarter. Arizona State Retirement System now owns 7,818 shares of the health services provider’s stock valued at $531,000 after buying an additional 100 shares during the last quarter. Victory Capital Management Inc. grew its position in shares of LHC Group by 0.3% in the 2nd quarter. Victory Capital Management Inc. now owns 48,920 shares of the health services provider’s stock valued at $3,321,000 after buying an additional 142 shares during the last quarter. Finally, Texas Permanent School Fund grew its position in shares of LHC Group by 1.4% in the 2nd quarter. Texas Permanent School Fund now owns 10,944 shares of the health services provider’s stock valued at $743,000 after buying an additional 153 shares during the last quarter. 85.93% of the stock is currently owned by hedge funds and other institutional investors.

Shares of LHC Group (LHCG) traded up 0.91% on Friday, reaching $65.47. 73,608 shares of the company’s stock traded hands. The company has a 50 day moving average of $63.81 and a 200-day moving average of $60.05. The stock has a market capitalization of $1.20 billion, a PE ratio of 28.97 and a beta of 0.76. LHC Group has a 52 week low of $32.04 and a 52 week high of $69.35.

LHC Group (NASDAQ:LHCG) last announced its earnings results on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.54 by $0.09. The firm had revenue of $260.20 million during the quarter, compared to analyst estimates of $254.10 million. LHC Group had a net margin of 4.13% and a return on equity of 9.62%. LHC Group’s revenue was up 15.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.52 EPS. Equities research analysts forecast that LHC Group will post $2.39 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This news story was first published by Daily Political and is the property of of Daily Political. If you are reading this news story on another website, it was illegally stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://www.dailypolitical.com/2017/09/24/lhc-group-lhcg-position-lifted-by-hood-river-capital-management-llc.html.

In related news, COO Donald Dwayne Stelly sold 2,650 shares of the stock in a transaction dated Friday, September 8th. The shares were sold at an average price of $65.34, for a total value of $173,151.00. Following the completion of the transaction, the chief operating officer now owns 109,235 shares in the company, valued at approximately $7,137,414.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 14.80% of the company’s stock.

A number of research firms recently commented on LHCG. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $70.00 target price on shares of LHC Group in a research report on Wednesday, September 6th. BidaskClub raised shares of LHC Group from a “hold” rating to a “buy” rating in a research report on Friday, August 18th. Zacks Investment Research raised shares of LHC Group from a “hold” rating to a “buy” rating and set a $67.00 price objective on the stock in a research report on Saturday, August 5th. Benchmark Co. raised their price objective on shares of LHC Group from $63.00 to $72.00 and gave the stock a “buy” rating in a research report on Thursday, June 8th. Finally, Jefferies Group LLC reissued a “buy” rating and set a $65.00 price objective on shares of LHC Group in a research report on Friday, June 9th. One investment analyst has rated the stock with a hold rating and ten have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $66.60.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group (NASDAQ:LHCG).

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.